Service interruption on Monday 11 July from 12:30 to 13:00: all the sites of the CCSD (HAL, Epiciences, SciencesConf, AureHAL) will be inaccessible (network hardware connection).
Skip to Main content Skip to Navigation
Journal articles

Low molecular weight heparin gels, based on nanoparticles, for topical delivery

Abstract : A commercial suspension of nanoparticles (Eudragit RS 30D) was used to manufacture a gel for topical application. Gels were prepared by mixing a polycationic polymer (Eudragit(®) RS 30D) and a low molecular weight heparin (LMWH), an antithrombotic agent. Gels formed spontaneously at a ratio of 1:1 as a result of electrostatic interactions between the polyanionic drug and the polycationic polymer. Different types of heparin were used: Bemiparin, Enoxaparin (Lovenox), Nadroparin (Fraxiparin) and Tinzaparin (Innohep). Several LMWH concentrations were tested. Rheological measurements were performed to investigate the gel behavior. Gel formation was confirmed by dynamic rheological measurements as the elastic modulus (G') was higher than the viscous one (G″). The amount of heparin incorporated into the gel matrix was determined. A maximum of incorporation (100%) was reached using a heparin solution of 600 IU/mL. The release kinetics of LMWH from the gel were also studied. Regardless of the LMWH used in the formulation, a biphasic release profile was observed. Accordingly, a burst effect was observed. Afterwards, the release rate became steady. The penetration of the LMWH through the dermal barrier was also investigated.
Document type :
Journal articles
Complete list of metadata
Contributor : Cithefor UL Connect in order to contact the contributor
Submitted on : Friday, March 17, 2017 - 3:38:37 PM
Last modification on : Sunday, June 26, 2022 - 6:00:33 AM



C. Loira-Pastoriza, A. Sapin-Minet, R. Diab, J.L. Grossiord, P. Maincent. Low molecular weight heparin gels, based on nanoparticles, for topical delivery. International Journal of Pharmaceutics, Elsevier, 2012, 426 (1-2), pp.256 - 262. ⟨10.1016/j.ijpharm.2012.01.044⟩. ⟨hal-01491900⟩



Record views